260 related articles for article (PubMed ID: 1906152)
1. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women.
Dodson WC; Walmer DK; Hughes CL; Yancy SE; Haney AF
Obstet Gynecol; 1991 Aug; 78(2):187-90. PubMed ID: 1906152
[TBL] [Abstract][Full Text] [Related]
2. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
Usui A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
[TBL] [Abstract][Full Text] [Related]
3. Role of gonadotropin releasing hormone agonists in ovulation induction.
Dodson WC
J Reprod Med; 1989 Jan; 34(1 Suppl):76-80. PubMed ID: 2497247
[TBL] [Abstract][Full Text] [Related]
4. Utility of gonadotropin-releasing hormone agonists in programs of ovarian hyperstimulation with intrauterine insemination.
Gagliardi CL
Clin Obstet Gynecol; 1993 Sep; 36(3):711-8. PubMed ID: 8403617
[TBL] [Abstract][Full Text] [Related]
5. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
[TBL] [Abstract][Full Text] [Related]
6. Midcycle administration of single-dose GnRHa for luteal phase failure in women with ovarian hyperstimulation. A report of five cases.
Wu TC
J Reprod Med; 2000 Feb; 45(2):156-8. PubMed ID: 10710751
[TBL] [Abstract][Full Text] [Related]
7. Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study.
Bahçeci M; Ulug U; Ben-Shlomo I; Erden HF; Akman MA
J Reprod Med; 2005 Feb; 50(2):84-90. PubMed ID: 15755044
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome.
Dodson WC; Hughes CL; Yancy SE; Haney AF
Fertil Steril; 1989 Dec; 52(6):915-8. PubMed ID: 2512181
[TBL] [Abstract][Full Text] [Related]
9. Controlled ovarian hyperstimulation for the new reproductive technologies.
Navot D; Sandler B
Acta Eur Fertil; 1989; 20(4):217-21. PubMed ID: 2519574
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous human menopausal gonadotropin administration for controlled ovarian hyperstimulation with intrauterine insemination cycles.
Kaplan PF; Austin DJ; Freund R
Am J Obstet Gynecol; 2000 Jun; 182(6):1421-6. PubMed ID: 10871458
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of nafarelin acetate versus leuprolide acetate in conjunction with human menopausal gonadotropins for superovulation/intrauterine insemination.
Schmidt-Sarosi CL; Yerovi LA
Int J Fertil Menopausal Stud; 1994; 39(1):20-5. PubMed ID: 8167676
[TBL] [Abstract][Full Text] [Related]
12. Minimal endometriosis and intrauterine insemination: does controlled ovarian hyperstimulation improve pregnancy rates?
Serta RT; Rufo S; Seibel MM
Obstet Gynecol; 1992 Jul; 80(1):37-40. PubMed ID: 1603494
[TBL] [Abstract][Full Text] [Related]
13. Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: a comparison among three different regimens.
Casadei L; Zamaro V; Calcagni M; Ticconi C; Dorrucci M; Piccione E
Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):155-61. PubMed ID: 16687201
[TBL] [Abstract][Full Text] [Related]
14. The use of GnRH analogues in combination with exogenous gonadotropins in infertile women.
Fleming R; Jamieson ME; Hamilton MP; Black WP; Macnaughton MC; Coutts JR
Acta Endocrinol Suppl (Copenh); 1988; 288():77-84. PubMed ID: 3138869
[TBL] [Abstract][Full Text] [Related]
15. Leuprolide acetate for inducing ovulation in women undergoing ovarian stimulation.
diDonato P; Nola VF; Pittman TV; Marr V; Stubbs C; Meldrum DR
J Reprod Med; 1995 Oct; 40(10):715-6. PubMed ID: 8551474
[TBL] [Abstract][Full Text] [Related]
16. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
[TBL] [Abstract][Full Text] [Related]
17. Progesterone response to exogenous gonadotropins after suppression with leuprolide acetate in gamete intrafallopian transfer.
Riemann DC; Schoolcraft WB; Sinton EB
J Reprod Med; 1991 Mar; 36(3):190-4. PubMed ID: 1903164
[TBL] [Abstract][Full Text] [Related]
18. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination.
Werbrouck E; Spiessens C; Meuleman C; D'Hooghe T
Fertil Steril; 2006 Sep; 86(3):566-71. PubMed ID: 16952506
[TBL] [Abstract][Full Text] [Related]
19. Opposite responses to the addition of leuprolide acetate to human menopausal gonadotropin therapy in two perimenopausal women.
Check JH; Adelson HG
Int J Fertil; 1990; 35(6):343-6. PubMed ID: 1981209
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
